img

Global GP Vaccination Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global GP Vaccination Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

GP Vaccination report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global GP Vaccination market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Adults and Children are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global GP Vaccination market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Takis Biotech
Zydus Cadila
Codagenix
GeoVax
Bravovax
Altimmune
Vaxart
Clover Biopharmaceuticals
ImmunoPrecise
Segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others

Segment by Application


Adults
Children

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the GP Vaccination market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of GP Vaccination, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the GP Vaccination industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of GP Vaccination in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, GP Vaccination introduction, etc. GP Vaccination Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of GP Vaccination market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 GP Vaccination Market Overview
1.1 GP Vaccination Product Overview
1.2 GP Vaccination Market Segment by Type
1.2.1 DNA
1.2.2 Non-replicating Viral Vector
1.2.3 Protein Subunit
1.2.4 RNA
1.2.5 Others
1.3 Global GP Vaccination Market Size by Type
1.3.1 Global GP Vaccination Market Size Overview by Type (2018-2029)
1.3.2 Global GP Vaccination Historic Market Size Review by Type (2018-2024)
1.3.3 Global GP Vaccination Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America GP Vaccination Sales Breakdown by Type (2018-2024)
1.4.2 Europe GP Vaccination Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific GP Vaccination Sales Breakdown by Type (2018-2024)
1.4.4 Latin America GP Vaccination Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa GP Vaccination Sales Breakdown by Type (2018-2024)
2 Global GP Vaccination Market Competition by Company
2.1 Global Top Players by GP Vaccination Sales (2018-2024)
2.2 Global Top Players by GP Vaccination Revenue (2018-2024)
2.3 Global Top Players by GP Vaccination Price (2018-2024)
2.4 Global Top Manufacturers GP Vaccination Manufacturing Base Distribution, Sales Area, Product Type
2.5 GP Vaccination Market Competitive Situation and Trends
2.5.1 GP Vaccination Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by GP Vaccination Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in GP Vaccination as of 2022)
2.7 Date of Key Manufacturers Enter into GP Vaccination Market
2.8 Key Manufacturers GP Vaccination Product Offered
2.9 Mergers & Acquisitions, Expansion
3 GP Vaccination Status and Outlook by Region
3.1 Global GP Vaccination Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global GP Vaccination Historic Market Size by Region
3.2.1 Global GP Vaccination Sales in Volume by Region (2018-2024)
3.2.2 Global GP Vaccination Sales in Value by Region (2018-2024)
3.2.3 Global GP Vaccination Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global GP Vaccination Forecasted Market Size by Region
3.3.1 Global GP Vaccination Sales in Volume by Region (2024-2029)
3.3.2 Global GP Vaccination Sales in Value by Region (2024-2029)
3.3.3 Global GP Vaccination Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global GP Vaccination by Application
4.1 GP Vaccination Market Segment by Application
4.1.1 Adults
4.1.2 Children
4.2 Global GP Vaccination Market Size by Application
4.2.1 Global GP Vaccination Market Size Overview by Application (2018-2029)
4.2.2 Global GP Vaccination Historic Market Size Review by Application (2018-2024)
4.2.3 Global GP Vaccination Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America GP Vaccination Sales Breakdown by Application (2018-2024)
4.3.2 Europe GP Vaccination Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific GP Vaccination Sales Breakdown by Application (2018-2024)
4.3.4 Latin America GP Vaccination Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa GP Vaccination Sales Breakdown by Application (2018-2024)
5 North America GP Vaccination by Country
5.1 North America GP Vaccination Historic Market Size by Country
5.1.1 North America GP Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America GP Vaccination Sales in Volume by Country (2018-2024)
5.1.3 North America GP Vaccination Sales in Value by Country (2018-2024)
5.2 North America GP Vaccination Forecasted Market Size by Country
5.2.1 North America GP Vaccination Sales in Volume by Country (2024-2029)
5.2.2 North America GP Vaccination Sales in Value by Country (2024-2029)
6 Europe GP Vaccination by Country
6.1 Europe GP Vaccination Historic Market Size by Country
6.1.1 Europe GP Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe GP Vaccination Sales in Volume by Country (2018-2024)
6.1.3 Europe GP Vaccination Sales in Value by Country (2018-2024)
6.2 Europe GP Vaccination Forecasted Market Size by Country
6.2.1 Europe GP Vaccination Sales in Volume by Country (2024-2029)
6.2.2 Europe GP Vaccination Sales in Value by Country (2024-2029)
7 Asia-Pacific GP Vaccination by Region
7.1 Asia-Pacific GP Vaccination Historic Market Size by Region
7.1.1 Asia-Pacific GP Vaccination Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific GP Vaccination Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific GP Vaccination Sales in Value by Region (2018-2024)
7.2 Asia-Pacific GP Vaccination Forecasted Market Size by Region
7.2.1 Asia-Pacific GP Vaccination Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific GP Vaccination Sales in Value by Region (2024-2029)
8 Latin America GP Vaccination by Country
8.1 Latin America GP Vaccination Historic Market Size by Country
8.1.1 Latin America GP Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America GP Vaccination Sales in Volume by Country (2018-2024)
8.1.3 Latin America GP Vaccination Sales in Value by Country (2018-2024)
8.2 Latin America GP Vaccination Forecasted Market Size by Country
8.2.1 Latin America GP Vaccination Sales in Volume by Country (2024-2029)
8.2.2 Latin America GP Vaccination Sales in Value by Country (2024-2029)
9 Middle East and Africa GP Vaccination by Country
9.1 Middle East and Africa GP Vaccination Historic Market Size by Country
9.1.1 Middle East and Africa GP Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa GP Vaccination Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa GP Vaccination Sales in Value by Country (2018-2024)
9.2 Middle East and Africa GP Vaccination Forecasted Market Size by Country
9.2.1 Middle East and Africa GP Vaccination Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa GP Vaccination Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Moderna
10.1.1 Moderna Company Information
10.1.2 Moderna Introduction and Business Overview
10.1.3 Moderna GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Moderna GP Vaccination Products Offered
10.1.5 Moderna Recent Development
10.2 CanSino Biologicals
10.2.1 CanSino Biologicals Company Information
10.2.2 CanSino Biologicals Introduction and Business Overview
10.2.3 CanSino Biologicals GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CanSino Biologicals GP Vaccination Products Offered
10.2.5 CanSino Biologicals Recent Development
10.3 Inovio Pharmaceuticals
10.3.1 Inovio Pharmaceuticals Company Information
10.3.2 Inovio Pharmaceuticals Introduction and Business Overview
10.3.3 Inovio Pharmaceuticals GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Inovio Pharmaceuticals GP Vaccination Products Offered
10.3.5 Inovio Pharmaceuticals Recent Development
10.4 Shenzhen Geno-Immune Medical Institute
10.4.1 Shenzhen Geno-Immune Medical Institute Company Information
10.4.2 Shenzhen Geno-Immune Medical Institute Introduction and Business Overview
10.4.3 Shenzhen Geno-Immune Medical Institute GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Shenzhen Geno-Immune Medical Institute GP Vaccination Products Offered
10.4.5 Shenzhen Geno-Immune Medical Institute Recent Development
10.5 GlaxoSmithKine
10.5.1 GlaxoSmithKine Company Information
10.5.2 GlaxoSmithKine Introduction and Business Overview
10.5.3 GlaxoSmithKine GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.5.4 GlaxoSmithKine GP Vaccination Products Offered
10.5.5 GlaxoSmithKine Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Information
10.6.2 Pfizer Introduction and Business Overview
10.6.3 Pfizer GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Pfizer GP Vaccination Products Offered
10.6.5 Pfizer Recent Development
10.7 Johnson＆Johnson
10.7.1 Johnson＆Johnson Company Information
10.7.2 Johnson＆Johnson Introduction and Business Overview
10.7.3 Johnson＆Johnson GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Johnson＆Johnson GP Vaccination Products Offered
10.7.5 Johnson＆Johnson Recent Development
10.8 Heat Biologics
10.8.1 Heat Biologics Company Information
10.8.2 Heat Biologics Introduction and Business Overview
10.8.3 Heat Biologics GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Heat Biologics GP Vaccination Products Offered
10.8.5 Heat Biologics Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Information
10.9.2 Sanofi Introduction and Business Overview
10.9.3 Sanofi GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Sanofi GP Vaccination Products Offered
10.9.5 Sanofi Recent Development
10.10 Takis Biotech
10.10.1 Takis Biotech Company Information
10.10.2 Takis Biotech Introduction and Business Overview
10.10.3 Takis Biotech GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Takis Biotech GP Vaccination Products Offered
10.10.5 Takis Biotech Recent Development
10.11 Zydus Cadila
10.11.1 Zydus Cadila Company Information
10.11.2 Zydus Cadila Introduction and Business Overview
10.11.3 Zydus Cadila GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Zydus Cadila GP Vaccination Products Offered
10.11.5 Zydus Cadila Recent Development
10.12 Codagenix
10.12.1 Codagenix Company Information
10.12.2 Codagenix Introduction and Business Overview
10.12.3 Codagenix GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Codagenix GP Vaccination Products Offered
10.12.5 Codagenix Recent Development
10.13 GeoVax
10.13.1 GeoVax Company Information
10.13.2 GeoVax Introduction and Business Overview
10.13.3 GeoVax GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.13.4 GeoVax GP Vaccination Products Offered
10.13.5 GeoVax Recent Development
10.14 Bravovax
10.14.1 Bravovax Company Information
10.14.2 Bravovax Introduction and Business Overview
10.14.3 Bravovax GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Bravovax GP Vaccination Products Offered
10.14.5 Bravovax Recent Development
10.15 Altimmune
10.15.1 Altimmune Company Information
10.15.2 Altimmune Introduction and Business Overview
10.15.3 Altimmune GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Altimmune GP Vaccination Products Offered
10.15.5 Altimmune Recent Development
10.16 Vaxart
10.16.1 Vaxart Company Information
10.16.2 Vaxart Introduction and Business Overview
10.16.3 Vaxart GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Vaxart GP Vaccination Products Offered
10.16.5 Vaxart Recent Development
10.17 Clover Biopharmaceuticals
10.17.1 Clover Biopharmaceuticals Company Information
10.17.2 Clover Biopharmaceuticals Introduction and Business Overview
10.17.3 Clover Biopharmaceuticals GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Clover Biopharmaceuticals GP Vaccination Products Offered
10.17.5 Clover Biopharmaceuticals Recent Development
10.18 ImmunoPrecise
10.18.1 ImmunoPrecise Company Information
10.18.2 ImmunoPrecise Introduction and Business Overview
10.18.3 ImmunoPrecise GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.18.4 ImmunoPrecise GP Vaccination Products Offered
10.18.5 ImmunoPrecise Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 GP Vaccination Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 GP Vaccination Industrial Chain Analysis
11.4 GP Vaccination Market Dynamics
11.4.1 GP Vaccination Industry Trends
11.4.2 GP Vaccination Market Drivers
11.4.3 GP Vaccination Market Challenges
11.4.4 GP Vaccination Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 GP Vaccination Distributors
12.3 GP Vaccination Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of DNA
Table 2. Major Company of Non-replicating Viral Vector
Table 3. Major Company of Protein Subunit
Table 4. Major Company of RNA
Table 5. Major Company of Others
Table 6. Global GP Vaccination Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global GP Vaccination Sales by Type (2018-2024) & (K Units)
Table 8. Global GP Vaccination Sales Market Share in Volume by Type (2018-2024)
Table 9. Global GP Vaccination Sales by Type (2018-2024) & (US& Million)
Table 10. Global GP Vaccination Market Share in Value by Type (2018-2024)
Table 11. Global GP Vaccination Price by Type (2018-2024) & (US$/Unit)
Table 12. Global GP Vaccination Sales by Type (2024-2029) & (K Units)
Table 13. Global GP Vaccination Sales Market Share in Volume by Type (2024-2029)
Table 14. Global GP Vaccination Sales by Type (2024-2029) & (US$ Million)
Table 15. Global GP Vaccination Sales Market Share in Value by Type (2024-2029)
Table 16. Global GP Vaccination Price by Type (2024-2029) & (US$/Unit)
Table 17. North America GP Vaccination Sales by Type (2018-2024) & (K Units)
Table 18. North America GP Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe GP Vaccination Sales (K Units) by Type (2018-2024)
Table 20. Europe GP Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific GP Vaccination Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific GP Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America GP Vaccination Sales (K Units) by Type (2018-2024)
Table 24. Latin America GP Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa GP Vaccination Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa GP Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 27. Global GP Vaccination Sales by Company (2018-2024) & (K Units)
Table 28. Global GP Vaccination Sales Share by Company (2018-2024)
Table 29. Global GP Vaccination Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global GP Vaccination Revenue Share by Company (2018-2024)
Table 31. Global Market GP Vaccination Price by Company (2018-2024) & (US$/Unit)
Table 32. Global GP Vaccination Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global GP Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in GP Vaccination as of 2022)
Table 35. Date of Key Manufacturers Enter into GP Vaccination Market
Table 36. Key Manufacturers GP Vaccination Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global GP Vaccination Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Global GP Vaccination Sales by Region (2018-2024) & (K Units)
Table 40. Global GP Vaccination Sales Market Share in Volume by Region (2018-2024)
Table 41. Global GP Vaccination Sales by Region (2018-2024) & (US$ Million)
Table 42. Global GP Vaccination Sales Market Share in Value by Region (2018-2024)
Table 43. Global GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 44. Global GP Vaccination Sales by Region (2024-2029) & (K Units)
Table 45. Global GP Vaccination Sales Market Share in Volume by Region (2024-2029)
Table 46. Global GP Vaccination Sales by Region (2024-2029) & (US$ Million)
Table 47. Global GP Vaccination Sales Market Share in Value by Region (2024-2029)
Table 48. Global GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 49. Global GP Vaccination Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 50. Global GP Vaccination Sales by Application (2018-2024) & (K Units)
Table 51. Global GP Vaccination Sales Market Share in Volume by Application (2018-2024)
Table 52. Global GP Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 53. Global GP Vaccination Sales Market Share in Value by Application (2018-2024)
Table 54. Global GP Vaccination Price by Application (2018-2024) & (US$/Unit)
Table 55. Global GP Vaccination Sales by Application (2024-2029) & (K Units)
Table 56. Global GP Vaccination Sales Market Share in Volume by Application (2024-2029)
Table 57. Global GP Vaccination Sales by Application (2024-2029) & (US$ Million)
Table 58. Global GP Vaccination Sales Market Share in Value by Application (2024-2029)
Table 59. Global GP Vaccination Price by Application (2024-2029) & (US$/Unit)
Table 60. North America GP Vaccination Sales by Application (2018-2024) (K Units)
Table 61. North America GP Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe GP Vaccination Sales by Application (2018-2024) (K Units)
Table 63. Europe GP Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific GP Vaccination Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific GP Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America GP Vaccination Sales by Application (2018-2024) (K Units)
Table 67. Latin America GP Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa GP Vaccination Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa GP Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 70. North America GP Vaccination Sales by Country (2018-2024) & (K Units)
Table 71. North America GP Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 72. North America GP Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 73. North America GP Vaccination Sales Market Share in Value by Country (2018-2024)
Table 74. North America GP Vaccination Sales by Country (2024-2029) & (K Units)
Table 75. North America GP Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 76. North America GP Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 77. North America GP Vaccination Sales Market Share in Value by Country (2024-2029)
Table 78. Europe GP Vaccination Sales by Country (2018-2024) & (K Units)
Table 79. Europe GP Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe GP Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe GP Vaccination Sales Market Share in Value by Country (2018-2024)
Table 82. Europe GP Vaccination Sales by Country (2024-2029) & (K Units)
Table 83. Europe GP Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 84. Europe GP Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 85. Europe GP Vaccination Sales Market Share in Value by Country (2024-2029)
Table 86. Asia-Pacific GP Vaccination Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific GP Vaccination Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific GP Vaccination Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific GP Vaccination Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific GP Vaccination Sales by Region (2024-2029) & (K Units)
Table 91. Asia-Pacific GP Vaccination Sales Market Share in Volume by Region (2024-2029)
Table 92. Asia-Pacific GP Vaccination Sales by Region (2024-2029) & (US$ Million)
Table 93. Asia-Pacific GP Vaccination Sales Market Share in Value by Region (2024-2029)
Table 94. Latin America GP Vaccination Sales by Country (2018-2024) & (K Units)
Table 95. Latin America GP Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America GP Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America GP Vaccination Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America GP Vaccination Sales by Country (2024-2029) & (K Units)
Table 99. Latin America GP Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 100. Latin America GP Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 101. Latin America GP Vaccination Sales Market Share in Value by Country (2024-2029)
Table 102. Middle East and Africa GP Vaccination Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa GP Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa GP Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa GP Vaccination Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa GP Vaccination Sales by Country (2024-2029) & (K Units)
Table 107. Middle East and Africa GP Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 108. Middle East and Africa GP Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 109. Middle East and Africa GP Vaccination Sales Market Share in Value by Country (2024-2029)
Table 110. Moderna Company Information
Table 111. Moderna Introduction and Business Overview
Table 112. Moderna GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Moderna GP Vaccination Product
Table 114. Moderna Recent Development
Table 115. CanSino Biologicals Company Information
Table 116. CanSino Biologicals Introduction and Business Overview
Table 117. CanSino Biologicals GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. CanSino Biologicals GP Vaccination Product
Table 119. CanSino Biologicals Recent Development
Table 120. Inovio Pharmaceuticals Company Information
Table 121. Inovio Pharmaceuticals Introduction and Business Overview
Table 122. Inovio Pharmaceuticals GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Inovio Pharmaceuticals GP Vaccination Product
Table 124. Inovio Pharmaceuticals Recent Development
Table 125. Shenzhen Geno-Immune Medical Institute Company Information
Table 126. Shenzhen Geno-Immune Medical Institute Introduction and Business Overview
Table 127. Shenzhen Geno-Immune Medical Institute GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Shenzhen Geno-Immune Medical Institute GP Vaccination Product
Table 129. Shenzhen Geno-Immune Medical Institute Recent Development
Table 130. GlaxoSmithKine Company Information
Table 131. GlaxoSmithKine Introduction and Business Overview
Table 132. GlaxoSmithKine GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. GlaxoSmithKine GP Vaccination Product
Table 134. GlaxoSmithKine Recent Development
Table 135. Pfizer Company Information
Table 136. Pfizer Introduction and Business Overview
Table 137. Pfizer GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Pfizer GP Vaccination Product
Table 139. Pfizer Recent Development
Table 140. Johnson＆Johnson Company Information
Table 141. Johnson＆Johnson Introduction and Business Overview
Table 142. Johnson＆Johnson GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Johnson＆Johnson GP Vaccination Product
Table 144. Johnson＆Johnson Recent Development
Table 145. Heat Biologics Company Information
Table 146. Heat Biologics Introduction and Business Overview
Table 147. Heat Biologics GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Heat Biologics GP Vaccination Product
Table 149. Heat Biologics Recent Development
Table 150. Sanofi Company Information
Table 151. Sanofi Introduction and Business Overview
Table 152. Sanofi GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Sanofi GP Vaccination Product
Table 154. Sanofi Recent Development
Table 155. Takis Biotech Company Information
Table 156. Takis Biotech Introduction and Business Overview
Table 157. Takis Biotech GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Takis Biotech GP Vaccination Product
Table 159. Takis Biotech Recent Development
Table 160. Zydus Cadila Company Information
Table 161. Zydus Cadila Introduction and Business Overview
Table 162. Zydus Cadila GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Zydus Cadila GP Vaccination Product
Table 164. Zydus Cadila Recent Development
Table 165. Codagenix Company Information
Table 166. Codagenix Introduction and Business Overview
Table 167. Codagenix GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Codagenix GP Vaccination Product
Table 169. Codagenix Recent Development
Table 170. GeoVax Company Information
Table 171. GeoVax Introduction and Business Overview
Table 172. GeoVax GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. GeoVax GP Vaccination Product
Table 174. GeoVax Recent Development
Table 175. Bravovax Company Information
Table 176. Bravovax Introduction and Business Overview
Table 177. Bravovax GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Bravovax GP Vaccination Product
Table 179. Bravovax Recent Development
Table 180. Altimmune Company Information
Table 181. Altimmune Introduction and Business Overview
Table 182. Altimmune GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Altimmune GP Vaccination Product
Table 184. Altimmune Recent Development
Table 185. Vaxart Company Information
Table 186. Vaxart Introduction and Business Overview
Table 187. Vaxart GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Vaxart GP Vaccination Product
Table 189. Vaxart Recent Development
Table 190. Clover Biopharmaceuticals Company Information
Table 191. Clover Biopharmaceuticals Introduction and Business Overview
Table 192. Clover Biopharmaceuticals GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 193. Clover Biopharmaceuticals GP Vaccination Product
Table 194. Clover Biopharmaceuticals Recent Development
Table 195. ImmunoPrecise Company Information
Table 196. ImmunoPrecise Introduction and Business Overview
Table 197. ImmunoPrecise GP Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 198. ImmunoPrecise GP Vaccination Product
Table 199. ImmunoPrecise Recent Development
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. GP Vaccination Market Trends
Table 203. GP Vaccination Market Drivers
Table 204. GP Vaccination Market Challenges
Table 205. GP Vaccination Market Restraints
Table 206. GP Vaccination Distributors List
Table 207. GP Vaccination Downstream Customers
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. GP Vaccination Product Picture
Figure 2. Global GP Vaccination Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global GP Vaccination Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global GP Vaccination Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of DNA
Figure 6. Global DNA Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Non-replicating Viral Vector
Figure 8. Global Non-replicating Viral Vector Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Protein Subunit
Figure 10. Global Protein Subunit Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of RNA
Figure 12. Global RNA Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Global GP Vaccination Sales by Type (2018-2029) & (US$ Million)
Figure 16. Global GP Vaccination Sales Market Share by Type in 2022 & 2029
Figure 17. North America GP Vaccination Sales Market Share in Volume by Type in 2022
Figure 18. North America GP Vaccination Sales Market Share in Value by Type in 2022
Figure 19. Europe GP Vaccination Sales Market Share in Volume by Type in 2022
Figure 20. Europe GP Vaccination Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific GP Vaccination Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific GP Vaccination Sales Market Share in Value by Type in 2022
Figure 23. Latin America GP Vaccination Sales Market Share in Volume by Type in 2022
Figure 24. Latin America GP Vaccination Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa GP Vaccination Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa GP Vaccination Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by GP Vaccination Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by GP Vaccination Revenue in 2022
Figure 29. GP Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Adults
Figure 31. Global Adults Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Children
Figure 33. Global Children Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global GP Vaccination Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global GP Vaccination Sales Market Share by Application in 2022 & 2029
Figure 36. North America GP Vaccination Sales Market Share in Volume by Application in 2022
Figure 37. North America GP Vaccination Sales Market Share in Value by Application in 2022
Figure 38. Europe GP Vaccination Sales Market Share in Volume by Application in 2022
Figure 39. Europe GP Vaccination Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific GP Vaccination Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific GP Vaccination Sales Market Share in Value by Application in 2022
Figure 42. Latin America GP Vaccination Sales Market Share in Volume by Application in 2022
Figure 43. Latin America GP Vaccination Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa GP Vaccination Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. GP Vaccination Manufacturing Cost Structure
Figure 47. GP Vaccination Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries